It’s a good day to be the pharmaceutical giant Eli Lilly. Right now, Eli Lilly appears to be the leader in the GLP-1 race amid multiple difficult headwinds for Novo Nordisk. As of this writing, Novo ...

Mon, February 16, 2026 at 7:00 PM UTC As of February 13, 2026, shares of Eli Lilly (NYSE:LLY) were trading at $1,040, just 5.8% below the stock's all-time high. Retail sentiment has turned decisively ...

Eli Lilly (LLY) reported Q4 EPS of $7.54 versus $6.67 expected. Eli Lilly projected 2026 revenue of $80-83B. Eli Lilly’s Mounjaro revenue surged 110% to $7.4B in Q4. Zepbound revenue jumped 123% to $4 ...

Feb 12 (Reuters) - Eli Lilly (LLY.N), opens new tab had $1.5 billion worth of pre-launch inventory of its experimental oral weight-loss drug, a filing showed on Thursday, ahead of an expected decision ...

Eli Lilly (LLY) shares turned lower in the premarket on Tuesday after its rival Novo Nordisk (NVO) announced plans to cut the list prices of its GLP-1 medications, Wegovy, Ozempic, and Rybelsus, in ...

Eli Lilly has been busy building its drug pipeline for the future. The company currently sells the world's best-selling drug. It just bought Orna Therapeutics, an innovative drugmaker. Investing in ...

The Computer Guy of Chicago strikes when you least expect. Sitting in a coffeehouse. Reading your phone on the train. Working out. Waiting for food. Walking down the street. When the Computer Guy ...

Too much of a good thing? Participants taking the highest dose of Eli Lilly’s new GLP-1 drug lost an average of 28.7% of their body weight in a late-stage trial, putting it on track to be a ...

UPPER MACUNGIE TWP., Pa. — Pharmaceutical giant Eli Lilly and Company is building a manufacturing campus in the Lehigh Valley, a multi-billion-dollar project that promises to create hundreds of new ...

Every time Hilary publishes a story, you’ll get an alert straight to your inbox! Enter your email By clicking “Sign up”, you agree to receive emails from ...